Life Sentence Handed Down In Fatal Counterfeit Diabetes Drug Case
This article was originally published in PharmAsia News
Executive Summary
The Kashgar District Intermediate People's Court recently sentenced eight defendants to prison time and fines for the manufacture and sale of counterfeit "glycolipid capsules" that resulted in the deaths of two diabetic patients in 2009